NanoRepro AG

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, LZAGY has a market cap of 44.8B. Regarding current trading prices, NNGRF is priced at $12.76, while LZAGY trades at $63.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas LZAGY's P/E ratio is 37.94. In terms of profitability, NNGRF's ROE is -0.05%, compared to LZAGY's ROE of +0.10%. Regarding short-term risk, NNGRF is less volatile compared to LZAGY. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check LZAGY's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, LZAGF has a market cap of 44.7B. Regarding current trading prices, NNGRF is priced at $12.76, while LZAGF trades at $635.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas LZAGF's P/E ratio is 38.29. In terms of profitability, NNGRF's ROE is -0.05%, compared to LZAGF's ROE of +0.10%. Regarding short-term risk, NNGRF is less volatile compared to LZAGF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check LZAGF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, WUXAY has a market cap of 44.6B. Regarding current trading prices, NNGRF is priced at $12.76, while WUXAY trades at $15.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas WUXAY's P/E ratio is 16.08. In terms of profitability, NNGRF's ROE is -0.05%, compared to WUXAY's ROE of +0.28%. Regarding short-term risk, NNGRF and WUXAY have similar daily volatility (0.00).Check WUXAY's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, WUXIF has a market cap of 41.4B. Regarding current trading prices, NNGRF is priced at $12.76, while WUXIF trades at $13.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas WUXIF's P/E ratio is 14.31. In terms of profitability, NNGRF's ROE is -0.05%, compared to WUXIF's ROE of +0.28%. Regarding short-term risk, NNGRF is less volatile compared to WUXIF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check WUXIF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, ERFSF has a market cap of 12.7B. Regarding current trading prices, NNGRF is priced at $12.76, while ERFSF trades at $73.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas ERFSF's P/E ratio is 24.15. In terms of profitability, NNGRF's ROE is -0.05%, compared to ERFSF's ROE of +0.12%. Regarding short-term risk, NNGRF is less volatile compared to ERFSF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check ERFSF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, BMXMF has a market cap of 12.4B. Regarding current trading prices, NNGRF is priced at $12.76, while BMXMF trades at $105.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas BMXMF's P/E ratio is 26.75. In terms of profitability, NNGRF's ROE is -0.05%, compared to BMXMF's ROE of +0.10%. Regarding short-term risk, NNGRF is less volatile compared to BMXMF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check BMXMF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, SKHHY has a market cap of 7.1B. Regarding current trading prices, NNGRF is priced at $12.76, while SKHHY trades at $14.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas SKHHY's P/E ratio is 18.27. In terms of profitability, NNGRF's ROE is -0.05%, compared to SKHHY's ROE of +0.05%. Regarding short-term risk, NNGRF is less volatile compared to SKHHY. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check SKHHY's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, SKHCF has a market cap of 7.1B. Regarding current trading prices, NNGRF is priced at $12.76, while SKHCF trades at $14.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas SKHCF's P/E ratio is 18.10. In terms of profitability, NNGRF's ROE is -0.05%, compared to SKHCF's ROE of +0.06%. Regarding short-term risk, NNGRF is less volatile compared to SKHCF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check SKHCF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, HNGZY has a market cap of 6.2B. Regarding current trading prices, NNGRF is priced at $12.76, while HNGZY trades at $4.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas HNGZY's P/E ratio is 26.67. In terms of profitability, NNGRF's ROE is -0.05%, compared to HNGZY's ROE of +0.04%. Regarding short-term risk, NNGRF is less volatile compared to HNGZY. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check HNGZY's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, DSRLF has a market cap of 3.9B. Regarding current trading prices, NNGRF is priced at $12.76, while DSRLF trades at $71.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas DSRLF's P/E ratio is 21.47. In terms of profitability, NNGRF's ROE is -0.05%, compared to DSRLF's ROE of +0.12%. Regarding short-term risk, NNGRF is less volatile compared to DSRLF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check DSRLF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, VIMGF has a market cap of 1.5B. Regarding current trading prices, NNGRF is priced at $12.76, while VIMGF trades at $2.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas VIMGF's P/E ratio is 39.57. In terms of profitability, NNGRF's ROE is -0.05%, compared to VIMGF's ROE of +0.05%. Regarding short-term risk, NNGRF is less volatile compared to VIMGF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check VIMGF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, GNTLF has a market cap of 1.3B. Regarding current trading prices, NNGRF is priced at $12.76, while GNTLF trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas GNTLF's P/E ratio is -16.67. In terms of profitability, NNGRF's ROE is -0.05%, compared to GNTLF's ROE of -1.85%. Regarding short-term risk, NNGRF and GNTLF have similar daily volatility (0.00).Check GNTLF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, MRCHF has a market cap of 1.1B. Regarding current trading prices, NNGRF is priced at $12.76, while MRCHF trades at $18.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas MRCHF's P/E ratio is 44.29. In terms of profitability, NNGRF's ROE is -0.05%, compared to MRCHF's ROE of +0.04%. Regarding short-term risk, NNGRF is less volatile compared to MRCHF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check MRCHF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, IDGXF has a market cap of 372M. Regarding current trading prices, NNGRF is priced at $12.76, while IDGXF trades at $0.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas IDGXF's P/E ratio is 16.00. In terms of profitability, NNGRF's ROE is -0.05%, compared to IDGXF's ROE of +0.28%. Regarding short-term risk, NNGRF is less volatile compared to IDGXF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check IDGXF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, EDTXF has a market cap of 297.8M. Regarding current trading prices, NNGRF is priced at $12.76, while EDTXF trades at $1.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas EDTXF's P/E ratio is -8.46. In terms of profitability, NNGRF's ROE is -0.05%, compared to EDTXF's ROE of +0.88%. Regarding short-term risk, NNGRF is less volatile compared to EDTXF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check EDTXF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, AMCY has a market cap of 171.3M. Regarding current trading prices, NNGRF is priced at $12.76, while AMCY trades at $3.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas AMCY's P/E ratio is N/A. In terms of profitability, NNGRF's ROE is -0.05%, compared to AMCY's ROE of N/A. Regarding short-term risk, NNGRF and AMCY have similar daily volatility (0.00).Check AMCY's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, DIUXF has a market cap of 141.3M. Regarding current trading prices, NNGRF is priced at $12.76, while DIUXF trades at $1.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas DIUXF's P/E ratio is -83.50. In terms of profitability, NNGRF's ROE is -0.05%, compared to DIUXF's ROE of -0.04%. Regarding short-term risk, NNGRF is less volatile compared to DIUXF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check DIUXF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, CORBF has a market cap of 127.3M. Regarding current trading prices, NNGRF is priced at $12.76, while CORBF trades at $0.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas CORBF's P/E ratio is 2.72. In terms of profitability, NNGRF's ROE is -0.05%, compared to CORBF's ROE of +0.11%. Regarding short-term risk, NNGRF and CORBF have similar daily volatility (0.00).Check CORBF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, LDXHF has a market cap of 99.2M. Regarding current trading prices, NNGRF is priced at $12.76, while LDXHF trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas LDXHF's P/E ratio is -13.00. In terms of profitability, NNGRF's ROE is -0.05%, compared to LDXHF's ROE of -1.21%. Regarding short-term risk, NNGRF and LDXHF have similar daily volatility (0.00).Check LDXHF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, THOXF has a market cap of 73.8M. Regarding current trading prices, NNGRF is priced at $12.76, while THOXF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas THOXF's P/E ratio is -7.45. In terms of profitability, NNGRF's ROE is -0.05%, compared to THOXF's ROE of -1.67%. Regarding short-term risk, NNGRF is less volatile compared to THOXF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check THOXF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, TIHE has a market cap of 71.9M. Regarding current trading prices, NNGRF is priced at $12.76, while TIHE trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas TIHE's P/E ratio is 0.32. In terms of profitability, NNGRF's ROE is -0.05%, compared to TIHE's ROE of +0.01%. Regarding short-term risk, NNGRF and TIHE have similar daily volatility (0.00).Check TIHE's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, PFGTF has a market cap of 69.8M. Regarding current trading prices, NNGRF is priced at $12.76, while PFGTF trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas PFGTF's P/E ratio is -3.41. In terms of profitability, NNGRF's ROE is -0.05%, compared to PFGTF's ROE of -1.30%. Regarding short-term risk, NNGRF is less volatile compared to PFGTF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check PFGTF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, BIOGF has a market cap of 65.4M. Regarding current trading prices, NNGRF is priced at $12.76, while BIOGF trades at $0.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas BIOGF's P/E ratio is -0.67. In terms of profitability, NNGRF's ROE is -0.05%, compared to BIOGF's ROE of +2.04%. Regarding short-term risk, NNGRF and BIOGF have similar daily volatility (0.00).Check BIOGF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, PCNEF has a market cap of 62M. Regarding current trading prices, NNGRF is priced at $12.76, while PCNEF trades at $2.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas PCNEF's P/E ratio is -8.44. In terms of profitability, NNGRF's ROE is -0.05%, compared to PCNEF's ROE of -0.05%. Regarding short-term risk, NNGRF is less volatile compared to PCNEF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check PCNEF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, BMKDF has a market cap of 44.5M. Regarding current trading prices, NNGRF is priced at $12.76, while BMKDF trades at $0.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas BMKDF's P/E ratio is -42.38. In terms of profitability, NNGRF's ROE is -0.05%, compared to BMKDF's ROE of -1.53%. Regarding short-term risk, NNGRF is less volatile compared to BMKDF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check BMKDF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, BIOQ has a market cap of 33.5M. Regarding current trading prices, NNGRF is priced at $12.76, while BIOQ trades at $37.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas BIOQ's P/E ratio is 15.83. In terms of profitability, NNGRF's ROE is -0.05%, compared to BIOQ's ROE of +0.01%. Regarding short-term risk, NNGRF is less volatile compared to BIOQ. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check BIOQ's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, SNANF has a market cap of 25.3M. Regarding current trading prices, NNGRF is priced at $12.76, while SNANF trades at $0.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas SNANF's P/E ratio is -11.07. In terms of profitability, NNGRF's ROE is -0.05%, compared to SNANF's ROE of -10.44%. Regarding short-term risk, NNGRF and SNANF have similar daily volatility (0.00).Check SNANF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, ANPCY has a market cap of 22M. Regarding current trading prices, NNGRF is priced at $12.76, while ANPCY trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas ANPCY's P/E ratio is -0.10. In terms of profitability, NNGRF's ROE is -0.05%, compared to ANPCY's ROE of -0.90%. Regarding short-term risk, NNGRF is less volatile compared to ANPCY. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check ANPCY's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, PCHM has a market cap of 22M. Regarding current trading prices, NNGRF is priced at $12.76, while PCHM trades at $3.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas PCHM's P/E ratio is -0.02. In terms of profitability, NNGRF's ROE is -0.05%, compared to PCHM's ROE of +0.25%. Regarding short-term risk, NNGRF is less volatile compared to PCHM. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check PCHM's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, VILGF has a market cap of 20.7M. Regarding current trading prices, NNGRF is priced at $12.76, while VILGF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas VILGF's P/E ratio is -0.30. In terms of profitability, NNGRF's ROE is -0.05%, compared to VILGF's ROE of N/A. Regarding short-term risk, NNGRF and VILGF have similar daily volatility (0.00).Check VILGF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, CLIFF has a market cap of 18M. Regarding current trading prices, NNGRF is priced at $12.76, while CLIFF trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas CLIFF's P/E ratio is -1.76. In terms of profitability, NNGRF's ROE is -0.05%, compared to CLIFF's ROE of -0.12%. Regarding short-term risk, NNGRF is less volatile compared to CLIFF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check CLIFF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, LDDD has a market cap of 15.3M. Regarding current trading prices, NNGRF is priced at $12.76, while LDDD trades at $0.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas LDDD's P/E ratio is -51.00. In terms of profitability, NNGRF's ROE is -0.05%, compared to LDDD's ROE of -0.28%. Regarding short-term risk, NNGRF is less volatile compared to LDDD. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check LDDD's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, IZOZF has a market cap of 13.9M. Regarding current trading prices, NNGRF is priced at $12.76, while IZOZF trades at $0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas IZOZF's P/E ratio is -10.10. In terms of profitability, NNGRF's ROE is -0.05%, compared to IZOZF's ROE of +0.48%. Regarding short-term risk, NNGRF is less volatile compared to IZOZF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check IZOZF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, ABDXF has a market cap of 13.3M. Regarding current trading prices, NNGRF is priced at $12.76, while ABDXF trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas ABDXF's P/E ratio is -1.40. In terms of profitability, NNGRF's ROE is -0.05%, compared to ABDXF's ROE of -0.45%. Regarding short-term risk, NNGRF and ABDXF have similar daily volatility (0.00).Check ABDXF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, IDXG has a market cap of 8.9M. Regarding current trading prices, NNGRF is priced at $12.76, while IDXG trades at $2.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas IDXG's P/E ratio is 2.25. In terms of profitability, NNGRF's ROE is -0.05%, compared to IDXG's ROE of +4.85%. Regarding short-term risk, NNGRF is less volatile compared to IDXG. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check IDXG's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, MXDHF has a market cap of 8.6M. Regarding current trading prices, NNGRF is priced at $12.76, while MXDHF trades at $0.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas MXDHF's P/E ratio is -0.12. In terms of profitability, NNGRF's ROE is -0.05%, compared to MXDHF's ROE of +5.17%. Regarding short-term risk, NNGRF and MXDHF have similar daily volatility (0.00).Check MXDHF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, JMPHF has a market cap of 8.1M. Regarding current trading prices, NNGRF is priced at $12.76, while JMPHF trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas JMPHF's P/E ratio is 4.28. In terms of profitability, NNGRF's ROE is -0.05%, compared to JMPHF's ROE of +0.31%. Regarding short-term risk, NNGRF is less volatile compared to JMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check JMPHF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, IMMVF has a market cap of 6.1M. Regarding current trading prices, NNGRF is priced at $12.76, while IMMVF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas IMMVF's P/E ratio is -0.50. In terms of profitability, NNGRF's ROE is -0.05%, compared to IMMVF's ROE of -5.64%. Regarding short-term risk, NNGRF is less volatile compared to IMMVF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check IMMVF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, AVCRF has a market cap of 6.1M. Regarding current trading prices, NNGRF is priced at $12.76, while AVCRF trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas AVCRF's P/E ratio is -6.03. In terms of profitability, NNGRF's ROE is -0.05%, compared to AVCRF's ROE of -0.95%. Regarding short-term risk, NNGRF is less volatile compared to AVCRF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check AVCRF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, SQIDF has a market cap of 6.1M. Regarding current trading prices, NNGRF is priced at $12.76, while SQIDF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas SQIDF's P/E ratio is -0.37. In terms of profitability, NNGRF's ROE is -0.05%, compared to SQIDF's ROE of +4.47%. Regarding short-term risk, NNGRF is less volatile compared to SQIDF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check SQIDF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, ICBU has a market cap of 5.4M. Regarding current trading prices, NNGRF is priced at $12.76, while ICBU trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas ICBU's P/E ratio is N/A. In terms of profitability, NNGRF's ROE is -0.05%, compared to ICBU's ROE of -0.22%. Regarding short-term risk, NNGRF is less volatile compared to ICBU. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check ICBU's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, PMSNF has a market cap of 5.2M. Regarding current trading prices, NNGRF is priced at $12.76, while PMSNF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas PMSNF's P/E ratio is -1.00. In terms of profitability, NNGRF's ROE is -0.05%, compared to PMSNF's ROE of +0.34%. Regarding short-term risk, NNGRF and PMSNF have similar daily volatility (0.00).Check PMSNF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, VRCDF has a market cap of 4.5M. Regarding current trading prices, NNGRF is priced at $12.76, while VRCDF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas VRCDF's P/E ratio is -0.10. In terms of profitability, NNGRF's ROE is -0.05%, compared to VRCDF's ROE of -1.93%. Regarding short-term risk, NNGRF is less volatile compared to VRCDF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check VRCDF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, RNVA has a market cap of 4.3M. Regarding current trading prices, NNGRF is priced at $12.76, while RNVA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas RNVA's P/E ratio is N/A. In terms of profitability, NNGRF's ROE is -0.05%, compared to RNVA's ROE of +0.23%. Regarding short-term risk, NNGRF and RNVA have similar daily volatility (0.00).Check RNVA's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, TDSGF has a market cap of 3.9M. Regarding current trading prices, NNGRF is priced at $12.76, while TDSGF trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas TDSGF's P/E ratio is -3.90. In terms of profitability, NNGRF's ROE is -0.05%, compared to TDSGF's ROE of -9.19%. Regarding short-term risk, NNGRF is less volatile compared to TDSGF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check TDSGF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, ANPCF has a market cap of 3.4M. Regarding current trading prices, NNGRF is priced at $12.76, while ANPCF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas ANPCF's P/E ratio is -0.17. In terms of profitability, NNGRF's ROE is -0.05%, compared to ANPCF's ROE of -0.90%. Regarding short-term risk, NNGRF is less volatile compared to ANPCF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check ANPCF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, IBXXF has a market cap of 2.2M. Regarding current trading prices, NNGRF is priced at $12.76, while IBXXF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas IBXXF's P/E ratio is -1.00. In terms of profitability, NNGRF's ROE is -0.05%, compared to IBXXF's ROE of +1.43%. Regarding short-term risk, NNGRF is less volatile compared to IBXXF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check IBXXF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, IVRO has a market cap of 1.8M. Regarding current trading prices, NNGRF is priced at $12.76, while IVRO trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas IVRO's P/E ratio is -0.80. In terms of profitability, NNGRF's ROE is -0.05%, compared to IVRO's ROE of +0.06%. Regarding short-term risk, NNGRF is less volatile compared to IVRO. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check IVRO's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, CHHL has a market cap of 1.8M. Regarding current trading prices, NNGRF is priced at $12.76, while CHHL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas CHHL's P/E ratio is N/A. In terms of profitability, NNGRF's ROE is -0.05%, compared to CHHL's ROE of +0.00%. Regarding short-term risk, NNGRF is less volatile compared to CHHL. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check CHHL's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, SLDX has a market cap of 1.6M. Regarding current trading prices, NNGRF is priced at $12.76, while SLDX trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas SLDX's P/E ratio is N/A. In terms of profitability, NNGRF's ROE is -0.05%, compared to SLDX's ROE of +0.17%. Regarding short-term risk, NNGRF is less volatile compared to SLDX. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check SLDX's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, DIGP has a market cap of 1.1M. Regarding current trading prices, NNGRF is priced at $12.76, while DIGP trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas DIGP's P/E ratio is -1.04. In terms of profitability, NNGRF's ROE is -0.05%, compared to DIGP's ROE of +1.19%. Regarding short-term risk, NNGRF is less volatile compared to DIGP. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check DIGP's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, EPGNF has a market cap of 982.2K. Regarding current trading prices, NNGRF is priced at $12.76, while EPGNF trades at $1.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas EPGNF's P/E ratio is -0.30. In terms of profitability, NNGRF's ROE is -0.05%, compared to EPGNF's ROE of +0.03%. Regarding short-term risk, NNGRF and EPGNF have similar daily volatility (0.00).Check EPGNF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, RSHN has a market cap of 857.6K. Regarding current trading prices, NNGRF is priced at $12.76, while RSHN trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas RSHN's P/E ratio is N/A. In terms of profitability, NNGRF's ROE is -0.05%, compared to RSHN's ROE of -5.42%. Regarding short-term risk, NNGRF is less volatile compared to RSHN. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check RSHN's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, IDTA has a market cap of 708K. Regarding current trading prices, NNGRF is priced at $12.76, while IDTA trades at $0.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas IDTA's P/E ratio is 8.75. In terms of profitability, NNGRF's ROE is -0.05%, compared to IDTA's ROE of +0.13%. Regarding short-term risk, NNGRF is less volatile compared to IDTA. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check IDTA's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, SZLSF has a market cap of 630K. Regarding current trading prices, NNGRF is priced at $12.76, while SZLSF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas SZLSF's P/E ratio is -0.04. In terms of profitability, NNGRF's ROE is -0.05%, compared to SZLSF's ROE of +4.82%. Regarding short-term risk, NNGRF is less volatile compared to SZLSF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check SZLSF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, SCRSF has a market cap of 600.3K. Regarding current trading prices, NNGRF is priced at $12.76, while SCRSF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas SCRSF's P/E ratio is -0.20. In terms of profitability, NNGRF's ROE is -0.05%, compared to SCRSF's ROE of +2.02%. Regarding short-term risk, NNGRF and SCRSF have similar daily volatility (0.00).Check SCRSF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, NSTM has a market cap of 493.3K. Regarding current trading prices, NNGRF is priced at $12.76, while NSTM trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas NSTM's P/E ratio is 0.20. In terms of profitability, NNGRF's ROE is -0.05%, compared to NSTM's ROE of -0.83%. Regarding short-term risk, NNGRF is less volatile compared to NSTM. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check NSTM's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, MBGNF has a market cap of 101.8K. Regarding current trading prices, NNGRF is priced at $12.76, while MBGNF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas MBGNF's P/E ratio is -0.59. In terms of profitability, NNGRF's ROE is -0.05%, compared to MBGNF's ROE of +0.26%. Regarding short-term risk, NNGRF is less volatile compared to MBGNF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check MBGNF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, NVTAQ has a market cap of 85.9K. Regarding current trading prices, NNGRF is priced at $12.76, while NVTAQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas NVTAQ's P/E ratio is -0.00. In terms of profitability, NNGRF's ROE is -0.05%, compared to NVTAQ's ROE of +0.00%. Regarding short-term risk, NNGRF is less volatile compared to NVTAQ. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check NVTAQ's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, ARYC has a market cap of 79.3K. Regarding current trading prices, NNGRF is priced at $12.76, while ARYC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas ARYC's P/E ratio is N/A. In terms of profitability, NNGRF's ROE is -0.05%, compared to ARYC's ROE of +0.55%. Regarding short-term risk, NNGRF is less volatile compared to ARYC. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check ARYC's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, HCLC has a market cap of 74K. Regarding current trading prices, NNGRF is priced at $12.76, while HCLC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas HCLC's P/E ratio is N/A. In terms of profitability, NNGRF's ROE is -0.05%, compared to HCLC's ROE of +0.11%. Regarding short-term risk, NNGRF and HCLC have similar daily volatility (0.00).Check HCLC's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, MEDD has a market cap of 63.8K. Regarding current trading prices, NNGRF is priced at $12.76, while MEDD trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas MEDD's P/E ratio is -0.02. In terms of profitability, NNGRF's ROE is -0.05%, compared to MEDD's ROE of +0.74%. Regarding short-term risk, NNGRF is less volatile compared to MEDD. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check MEDD's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, IHTI has a market cap of 32.5K. Regarding current trading prices, NNGRF is priced at $12.76, while IHTI trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas IHTI's P/E ratio is N/A. In terms of profitability, NNGRF's ROE is -0.05%, compared to IHTI's ROE of +0.00%. Regarding short-term risk, NNGRF is less volatile compared to IHTI. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check IHTI's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, TOMDF has a market cap of 14.1K. Regarding current trading prices, NNGRF is priced at $12.76, while TOMDF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas TOMDF's P/E ratio is N/A. In terms of profitability, NNGRF's ROE is -0.05%, compared to TOMDF's ROE of +0.84%. Regarding short-term risk, NNGRF is less volatile compared to TOMDF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check TOMDF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, CGNH has a market cap of 12K. Regarding current trading prices, NNGRF is priced at $12.76, while CGNH trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas CGNH's P/E ratio is N/A. In terms of profitability, NNGRF's ROE is -0.05%, compared to CGNH's ROE of +1.41%. Regarding short-term risk, NNGRF and CGNH have similar daily volatility (0.00).Check CGNH's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, ABMC has a market cap of 4.8K. Regarding current trading prices, NNGRF is priced at $12.76, while ABMC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas ABMC's P/E ratio is 0.01. In terms of profitability, NNGRF's ROE is -0.05%, compared to ABMC's ROE of +0.86%. Regarding short-term risk, NNGRF and ABMC have similar daily volatility (0.00).Check ABMC's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, CYPS has a market cap of 4.1K. Regarding current trading prices, NNGRF is priced at $12.76, while CYPS trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas CYPS's P/E ratio is N/A. In terms of profitability, NNGRF's ROE is -0.05%, compared to CYPS's ROE of N/A. Regarding short-term risk, NNGRF and CYPS have similar daily volatility (0.00).Check CYPS's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, RGDXQ has a market cap of 3.9K. Regarding current trading prices, NNGRF is priced at $12.76, while RGDXQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas RGDXQ's P/E ratio is N/A. In terms of profitability, NNGRF's ROE is -0.05%, compared to RGDXQ's ROE of -1.27%. Regarding short-term risk, NNGRF is less volatile compared to RGDXQ. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check RGDXQ's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, DMTKQ has a market cap of 3.5K. Regarding current trading prices, NNGRF is priced at $12.76, while DMTKQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas DMTKQ's P/E ratio is -0.00. In terms of profitability, NNGRF's ROE is -0.05%, compared to DMTKQ's ROE of -1.06%. Regarding short-term risk, NNGRF and DMTKQ have similar daily volatility (0.00).Check DMTKQ's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, MEDVF has a market cap of 2.7K. Regarding current trading prices, NNGRF is priced at $12.76, while MEDVF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas MEDVF's P/E ratio is N/A. In terms of profitability, NNGRF's ROE is -0.05%, compared to MEDVF's ROE of +2.13%. Regarding short-term risk, NNGRF is less volatile compared to MEDVF. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check MEDVF's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, GWHP has a market cap of 1.3K. Regarding current trading prices, NNGRF is priced at $12.76, while GWHP trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas GWHP's P/E ratio is -0.00. In terms of profitability, NNGRF's ROE is -0.05%, compared to GWHP's ROE of +6.19%. Regarding short-term risk, NNGRF is less volatile compared to GWHP. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check GWHP's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, ROSGQ has a market cap of 593. Regarding current trading prices, NNGRF is priced at $12.76, while ROSGQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas ROSGQ's P/E ratio is N/A. In terms of profitability, NNGRF's ROE is -0.05%, compared to ROSGQ's ROE of -1.35%. Regarding short-term risk, NNGRF and ROSGQ have similar daily volatility (0.00).Check ROSGQ's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, BIOCQ has a market cap of 263. Regarding current trading prices, NNGRF is priced at $12.76, while BIOCQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas BIOCQ's P/E ratio is N/A. In terms of profitability, NNGRF's ROE is -0.05%, compared to BIOCQ's ROE of -1.38%. Regarding short-term risk, NNGRF and BIOCQ have similar daily volatility (0.00).Check BIOCQ's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, HTGMQ has a market cap of 221. Regarding current trading prices, NNGRF is priced at $12.76, while HTGMQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas HTGMQ's P/E ratio is N/A. In terms of profitability, NNGRF's ROE is -0.05%, compared to HTGMQ's ROE of -2.73%. Regarding short-term risk, NNGRF and HTGMQ have similar daily volatility (0.00).Check HTGMQ's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, OPGX has a market cap of 17. Regarding current trading prices, NNGRF is priced at $12.76, while OPGX trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas OPGX's P/E ratio is -0.00. In terms of profitability, NNGRF's ROE is -0.05%, compared to OPGX's ROE of +0.46%. Regarding short-term risk, NNGRF is less volatile compared to OPGX. This indicates potentially lower risk in terms of short-term price fluctuations for NNGRF.Check OPGX's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, MRPS has a market cap of 0. Regarding current trading prices, NNGRF is priced at $12.76, while MRPS trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas MRPS's P/E ratio is N/A. In terms of profitability, NNGRF's ROE is -0.05%, compared to MRPS's ROE of N/A. Regarding short-term risk, NNGRF and MRPS have similar daily volatility (0.00).Check MRPS's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, EPGNY has a market cap of 0. Regarding current trading prices, NNGRF is priced at $12.76, while EPGNY trades at $2.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas EPGNY's P/E ratio is -1.60. In terms of profitability, NNGRF's ROE is -0.05%, compared to EPGNY's ROE of -0.19%. Regarding short-term risk, NNGRF and EPGNY have similar daily volatility (0.00).Check EPGNY's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, AGHC has a market cap of 0. Regarding current trading prices, NNGRF is priced at $12.76, while AGHC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas AGHC's P/E ratio is N/A. In terms of profitability, NNGRF's ROE is -0.05%, compared to AGHC's ROE of +2.90%. Regarding short-term risk, NNGRF and AGHC have similar daily volatility (0.00).Check AGHC's competition here

NNGRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NNGRF stands at 164.3M. In comparison, BGNX has a market cap of 0. Regarding current trading prices, NNGRF is priced at $12.76, while BGNX trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NNGRF currently has a P/E ratio of 60.75, whereas BGNX's P/E ratio is N/A. In terms of profitability, NNGRF's ROE is -0.05%, compared to BGNX's ROE of N/A. Regarding short-term risk, NNGRF and BGNX have similar daily volatility (0.00).Check BGNX's competition here